Archynetys Live news trend intelligence
◼ Archived Technology 🔮 Archynetys predicts: fades by tomorrow — graded ✓ correct

Wooly Mammoth startup Colossal seeking at least $20B valuation

De-extinction startup Colossal Biosciences is reportedly seeking a valuation between $20 billion and $30 billion in a new funding round.

By · Published July 22, 2026 at 16:22 UTC · Updated July 23, 2026 at 03:37 UTC

5sources
5articles
3velocity
+0%since first seen
45d agofirst detected

Evidence dossier

Intelligence passport

56/100 Publishable
5distinct sources shown
40velocity measurements
1language editions checked
All brief claims passed the second-source checkbrief evidence status

Measured timeline

  1. Detected The first matching coverage entered the Archynetys cluster.
  2. Latest coverage observed Most recent article currently attached to this story cluster.
  3. Peak measured velocity The recorded velocity reached 3.
  4. Evidence threshold reached The story had enough independent coverage for an explanatory brief.
  5. Outcome review added Archynetys revisited the signal after coverage cooled.

Source diversity sample: Межа. Новини України. · Zamin.uz · Seeking Alpha · TechCrunch · Axios.

How this dossier is built: methodology · AI policy · corrections.

📍 Aftermath

Colossal Biosciences reportedly entered talks to raise new capital. The de-extinction startup sought a valuation between $20 billion and $30 billion.

Epilogue added 43d ago, after coverage quieted.

The obvious questions

What is Colossal Biosciences' primary focus?

The company is a de-extinction startup known for its work with the wooly mammoth.

What valuation is the company seeking?

Colossal is seeking a valuation of at least $20 billion, with some reports placing the target between $20 billion and $30 billion.

What is the current status of the funding?

According to reports, the company is currently in talks to raise new capital.

The story so far

Colossal Biosciences, a startup focused on de-extinction and the wooly mammoth, is in talks to raise new capital. The company is seeking a valuation of at least $20 billion, with some reports indicating a target as high as $30 billion.

Coverage from TechCrunch, Axios, Seeking Alpha, Zamin.uz, and Межа. Новини України emphasizes the scale of the potential valuation. The reporting consistently identifies the company as a de-extinction venture specifically associated with the wooly mammoth.

Future developments depend on the outcome of these funding discussions and whether the company achieves the reported $20 billion to $30 billion valuation.

Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 44d ago.

Sources (5)

How fast it spread

How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →

Topics

Colossal Biosciences De-extinction Wooly Mammoth Venture Capital

Related trends

Open prediction lab

Can you beat the machine?

Pick tomorrow's top trend, then compare your result with Archynetys's self-graded forecast.

Make a prediction →